Insider Selling: Milestone Scientific Inc. (NYSE:MLSS) Major Shareholder Sells 50,853 Shares of Stock

Milestone Scientific Inc. (NYSE:MLSS - Get Free Report) major shareholder S.R.L. Bp4 sold 50,853 shares of the company's stock in a transaction dated Thursday, July 3rd. The shares were sold at an average price of $0.67, for a total transaction of $34,071.51. Following the sale, the insider directly owned 9,350,846 shares in the company, valued at approximately $6,265,066.82. This trade represents a 0.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Large shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.

S.R.L. Bp4 also recently made the following trade(s):

• On Tuesday, July 8th, S.R.L. Bp4 sold 11,489 shares of Milestone Scientific stock. The shares were sold at an average price of $0.69, for a total transaction of $7,927.41.
• On Monday, July 7th, S.R.L. Bp4 sold 30,558 shares of Milestone Scientific stock. The shares were sold at an average price of $0.68, for a total value of $20,779.44.
• On Monday, June 30th, S.R.L. Bp4 sold 649 shares of Milestone Scientific stock. The shares were sold at an average price of $0.65, for a total value of $421.85.
• On Friday, June 27th, S.R.L. Bp4 sold 10,000 shares of Milestone Scientific stock. The shares were sold at an average price of $0.73, for a total value of $7,300.00.
• On Wednesday, June 25th, S.R.L. Bp4 sold 1,300 shares of Milestone Scientific stock. The shares were sold at an average price of $0.77, for a total value of $1,001.00.
• On Tuesday, June 24th, S.R.L. Bp4 sold 10,000 shares of Milestone Scientific stock. The stock was sold at an average price of $0.81, for a total transaction of $8,100.00.
• On Monday, June 23rd, S.R.L. Bp4 sold 5,933 shares of Milestone Scientific stock. The stock was sold at an average price of $0.86, for a total transaction of $5,102.38.
• On Wednesday, June 18th, S.R.L. Bp4 sold 1,693 shares of Milestone Scientific stock. The stock was sold at an average price of $0.88, for a total transaction of $1,489.84.
• On Monday, June 16th, S.R.L. Bp4 sold 10,056 shares of Milestone Scientific stock. The stock was sold at an average price of $0.90, for a total transaction of $9,050.40.
• On Wednesday, June 11th, S.R.L. Bp4 sold 23,797 shares of Milestone Scientific stock. The stock was sold at an average price of $0.90, for a total value of $21,417.30.

Milestone Scientific Stock Performance

MLSS traded down $0.00 during midday trading on Friday, hitting $0.67. The stock had a trading volume of 30,710 shares, compared to its average volume of 120,147. The company has a market cap of $52.30 million, a P/E ratio of -9.52 and a beta of 0.80. Milestone Scientific Inc. has a 1 year low of $0.57 and a 1 year high of $1.39. The business has a fifty day moving average of $0.86 and a 200 day moving average of $0.98.

Institutional Trading of Milestone Scientific

Institutional investors have recently made changes to their positions in the stock. XTX Topco Ltd lifted its stake in Milestone Scientific by 99.2% in the first quarter. XTX Topco Ltd now owns 34,135 shares of the company's stock worth $32,000 after acquiring an additional 17,002 shares during the period. Brookwood Investment Group LLC purchased a new stake in Milestone Scientific in the first quarter worth $46,000. Finally, Renaissance Technologies LLC lifted its stake in Milestone Scientific by 72.8% in the fourth quarter. Renaissance Technologies LLC now owns 126,275 shares of the company's stock worth $121,000 after acquiring an additional 53,198 shares during the period. Hedge funds and other institutional investors own 5.79% of the company's stock.

Analysts Set New Price Targets

Separately, Wall Street Zen assumed coverage on Milestone Scientific in a research note on Sunday, May 18th. They issued a "hold" rating for the company.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.